Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system
| Autor: | Tang, Annie, Neeman, Elad, Vuong, Brooke, Arasu, Vignesh A, Liu, Raymond, Kuehner, Gillian E, Savitz, Alison C, Lyon, Liisa L, Anshu, Prachi, Seaward, Samantha A, Patel, Milan D, Habel, Laurel A, Kushi, Lawrence H, Mentakis, Margaret, Thomas, Eva S, Kolevska, Tatjana, Chang, Sharon B, Permanente Medical Group Breast Research Collaborative |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
SARS-CoV-2
Clinical Trials and Supportive Activities Clinical Sciences Oncology and Carcinogenesis COVID-19 Treatment times Breast Neoplasms Presentation Telehealth Good Health and Well Being Clinical Research Integrated Breast Cancer Permanente Medical Group Breast Research Collaborative Humans Female Breast Oncology & Carcinogenesis Delivery of Health Care Pandemics Cancer |
| Zdroj: | Breast cancer research and treatment, vol 191, iss 3 |
| Popis: | PurposesTo delineate operational changes in Kaiser Permanente Northern California breast care and evaluate the impact of these changes during the initial COVID-19 Shelter-in-Place period (SiP, 3/17/20-5/17/20).MethodsBy extracting data from institutional databases and reviewing electronic medical charts, we compared clinical and treatment characteristics of breast cancer patients diagnosed 3/17/20-5/17/20 to those diagnosed 3/17/19-5/17/2019. Outcomes included time from biopsy to consultation and treatment. Comparisons were made using Chi-square or Wilcoxon rank-sum tests.ResultsFewer new breast cancers were diagnosed in 2020 during the SiP period than during a similar period in 2019 (n = 247 vs n = 703). A higher percentage presented with symptomatic disease in 2020 than 2019 (78% vs 37%, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|